Dr. Reddy's Laboratories Files Routine 6-K

Ticker: RDY · Form: 6-K · Filed: Aug 26, 2025 · CIK: 1135951

Sentiment: neutral

Topics: reporting, foreign-issuer, sec-filing

TL;DR

DRL filed a 6-K, standard procedure for foreign issuers. No major news.

AI Summary

Dr. Reddy's Laboratories Limited filed a Form 6-K on August 26, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer. This filing is routine and does not contain specific financial or operational updates beyond its classification and reporting status.

Why It Matters

This filing confirms Dr. Reddy's Laboratories' status as a foreign private issuer and its adherence to SEC reporting requirements for companies outside the United States.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain market-moving information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.

When was this Form 6-K filed?

This Form 6-K was filed on August 26, 2025.

What is the Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Ltd?

The SIC code for Dr. Reddy's Laboratories Ltd is 2834, which corresponds to Pharmaceutical Preparations.

Where is Dr. Reddy's Laboratories Ltd's principal executive office located?

The principal executive office of Dr. Reddy's Laboratories Ltd is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Does Dr. Reddy's Laboratories Ltd file annual reports under Form 20-F?

Yes, the filing indicates that Dr. Reddy's Laboratories Ltd files annual reports under cover of Form 20-F.

Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-08-26 09:17:40

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: August 26, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing